Clearpoint Neuro is trading 5.9% up at $14.95 in pre-market as broader market tailwinds and a strong risk-on tone lift equities.
- The stock is rebounding from a modest slide last week, tracking higher alongside major U.S. indices and futures.
- Overall market sentiment has improved following easing Middle East tensions and a decline in oil prices.
- No fresh company-specific news or earnings have been reported to account for the individual price action.